Evidence map›Paper›PMID 23691243›Full record

ArticlePloS one2013

WAVE2 regulates epithelial morphology and cadherin isoform switching through regulation of Twist and Abl.

Nicole S Bryce, Albert B Reynolds, Anthony J Koleske, Alissa M Weaver

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Nicole S BryceDepartment of Cancer Biology, Vanderbilt University Medical Center, Nashville, Tennessee, United States of America.
Albert B Reynolds
Anthony J Koleske
Alissa M Weaver
Vanderbilt University Medical Center · USYale University · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Jin Chen · 1995 to 2026
$172.8M
Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MARCUS W BOSENBERG · 1985 to 2026
$85.0M
TISSUE CoreP50CA098131 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PARK, BEN HO, PIETENPOL, JENNIFER A · 2003 to 2024
$48.7M
TrainingU54CA113007 · NCI · VANDERBILT UNIVERSITY · PI ESTRADA-RODGERS, LOURDES · 2004 to 2014
$19.2M
Roles of Abl and Arg Neuronal DevelopmentR01NS039475 · NINDS · YALE UNIVERSITY · PI KOLESKE, ANTHONY J · 2000 to 2012
$4.3M
Supplement to Regulation of invadopodia formation in breast cancer cellsR01CA133346 · NCI · YALE UNIVERSITY · PI KOLESKE, ANTHONY J · 2009 to 2016
$2.3M
A mouse model for p120 downregulation in cancerR01CA111947 · NCI · VANDERBILT UNIVERSITY · PI REYNOLDS, ALBERT B · 2005 to 2009
$1.7M
Cortactin function in lamellipodial protrusionR01GM075126 · NIGMS · VANDERBILT UNIVERSITY · PI WEAVER, ALISSA M · 2007 to 2011
$1.4M
The mechanism of Arg kinase activation by integrin B1R01GM100411 · NIGMS · YALE UNIVERSITY · PI BOGGON, TITUS JONATHON, KOLESKE, ANTHONY J · 2012 to 2015
$1.3M
NCI NIH HHS 5P50CA098131NCI NIH HHS P30 CA016359NCI NIH HHS P30 CA068485NCI NIH HHS P30-CA068485NCI NIH HHS P50 CA098131NCI NIH HHS R01 CA111947NCI NIH HHS R01 CA133346NCI NIH HHS R01CA133346NCI NIH HHS U54 CA113007NCI NIH HHS U54CA113007NIGMS NIH HHS R01 GM075126NIGMS NIH HHS R01GM075126NIGMS NIH HHS R01 GM100411NINDS NIH HHS R01 NS039475NINDS NIH HHS R01NS39475
6 · The paper itself

Abstract

backgroundEpithelial morphogenesis is a dynamic process that involves coordination of signaling and actin cytoskeletal rearrangements. PRINCIPAL

findingsWe analyzed the contribution of the branched actin regulator WAVE2 in the development of 3-dimensional (3D) epithelial structures. WAVE2-knockdown (WAVE2-KD) cells formed large multi-lobular acini that continued to proliferate at an abnormally late stage compared to control acini. Immunostaining of the cell-cell junctions of WAVE2-KD acini revealed weak and heterogeneous E-cadherin staining despite little change in actin filament localization to the same junctions. Analysis of cadherin expression demonstrated a decrease in E-cadherin and an increase in N-cadherin protein and mRNA abundance in total cell lysates. In addition, WAVE2-KD cells exhibited an increase in the mRNA levels of the epithelial-mesenchymal transition (EMT)-associated transcription factor Twist1. KD of Twist1 expression in WAVE2-KD cells reversed the cadherin switching and completely rescued the aberrant 3D morphological phenotype. Activity of the WAVE2 complex binding partner Abl kinase was also increased in WAVE2-KD cells, as assessed by tyrosine phosphorylation of the Abl substrate CrkL. Inhibition of Abl with STI571 rescued the multi-lobular WAVE2-KD 3D phenotype whereas overexpression of Abl kinase phenocopied the WAVE2-KD phenotype.

conclusionsThe WAVE2 complex regulates breast epithelial morphology by a complex mechanism involving repression of Twist1 expression and Abl kinase activity. These data reveal a critical role for WAVE2 complex in regulation of cellular signaling and epithelial morphogenesis.

Indexed as

CadherinsEpithelial-Mesenchymal TransitionHumansNuclear ProteinsProtein IsoformsProto-Oncogene Proteins c-ablReal-Time Polymerase Chain ReactionTwist-Related Protein 1Wiskott-Aldrich Syndrome Protein FamilyCadherinsNuclear ProteinsProtein IsoformsProto-Oncogene Proteins c-ablTWIST1 protein, humanTwist-Related Protein 1WASF2 protein, humanWiskott-Aldrich Syndrome Protein Family

Identifiers

PMID23691243
PMCPMC3654908
OpenAlexW2077194459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.